BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
See today's BioWorld
Home
» Other news to note for March 9, 2021
X
Upgrade your daily dose of biopharma and medtech news
Subscribe to BioWorld™ news services
See subscription options
To read the full article
sign up for free
or
sign in
.
Other news to note for March 9, 2021
March 9, 2021
No Comments
Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: AC Immune, Affinivax, Allarity, Arkuda, Asceneuron, Biodextris, Biolojic, Boston Immune, Cambridge Allergy, Capricor, Centogene, Compugen, Dewpoint, Durect, Eli Lilly, Exevir, Genome and Co., Greenlight, Immunitybio, Immunoscape, Insilico, Medolife, Merck & Co., Merck KGaA, Nantkwest, Neurorx, Oragenics, Orionis, Pfizer, Promatix, PTC, Scisparc, Selexis, Soligenix, Sorrento, Surface Oncology, Taysha, TFF, Twelve Bio, UCB, Valo, Volastra, Yumanity.
BioWorld
Briefs
Other news to note
Coronavirus